Interplay between two myogenesis-related proteins: TBP-interacting protein 120B and MyoD

Gene

Volumn 504, Issue 2, 2012, Pages 213-219

  Suzuki, Hidefumi ^a   Suzuki, Ai ^a   Maekawa, Yui ^a   Shiraishi, Seiji ^a,b   Tamura, Taka aki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

Author keywords

CAND2; MyoD; Myogenesis; TIP120B; Transcriptional regulation

Indexed keywords

DEXAMETHASONE; MYOD PROTEIN; MYOGENIN; PROTEASOME; PROTEIN; TATA BINDING PROTEIN INTERACTING PROTEIN 120B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CHROMATIN; MOUSE; MUSCLE DEVELOPMENT; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY;

CHROMATIN IMMUNOPRECIPITATION; HUMANS; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MYOD PROTEIN; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 84862768812     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.05.022     Document Type: Article

References (32)

1. Aoki T., et al. TIP120B: a novel TIP120-family protein that is expressed specifically in muscle tissues. Biochem. Biophys. Res. Commun. 1999, 261:911-916.
2. Aoki T., Okada N., Wakamatsu T., Tamura T.A. TBP-interacting protein 120B, which is induced in relation to myogenesis, binds to NOT3. Biochem. Biophys. Res. Commun. 2002, 296:1097-1103.
3. Berkes C.A., Tapscott S.J. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 2005, 16:585-595.
4. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
5. Etzioni S., et al. Homodimeric MyoD preferentially binds tetraplex structures of regulatory sequences of muscle-specific genes. J. Biol. Chem. 2005, 280:26805-26812.
6. Florini J.R., Ewton D.Z., Coolican S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 1996, 17:481-517.
7. Fujisawa-Sehara A., Nabeshima Y., Hosoda Y., Obinata T., Nabeshima Y. Myogenin contains two domains conserved among myogenic factors. J. Biol. Chem. 1990, 265:15219-15223.
8. Halevy O., et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995, 267:1018-1021.
9. Jogo M., Shiraishi S., Tamura T.A. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase. FEBS Lett. 2009, 583:2715-2719.
10. Kayukawa K., Kitajima Y., Tamura T. TBP-interacting protein TIP120A is a new global transcription activator with bipartite functional domains. Genes Cells 2001, 6:165-174.
11. Kitamura T., Suzuki H., Tamura T. Mouse Wee1 gene is repressed by Krüppel-like factor 3 (KLF3) via interaction with multiple upstream elements. Gene 2012, 25:361-367.
12. Konishi Y., et al. Transcriptional regulation of mouse type 1 inositol 1,4,5-trisphosphate receptor gene by NeuroD-related factor. J. Neurochem. 1999, 72:1717-1724.
13. Koyama S., et al. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. J. Mol. Biol. 2008, 376:1224-1236.
14. Lassar A.B., et al. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 1989, 58:823-831.
15. Lecker S.H., Solomon V., Mitch W.E., Goldberg A.L. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 1999, 129:227S-237S.
16. Lingbeck J.M., Trausch-Azar J.S., Ciechanover A., Schwartz A.L. E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1. Oncogene 2005, 24:6376-6384.
17. Min K.W., et al. CAND1 enhances deneddylation of CUL1 by COP9 signalosome. Biochem. Biophys. Res. Commun. 2005, 334:867-874.
18. Mitch W.E., Goldberg A.L. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 1996, 335:1897-1905.
19. Nabeshima Y., et al. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 1993, 364:532-535.
20. Puri P.L., Sartorelli V. Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J. Cell. Physiol. 2000, 185:155-173.
21. Sacheck J.M., Ohtsuka A., McLary S.C., Goldberg A.L. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am. J. Physiol. Endocrinol. Metab. 2004, 287:591-601.
22. 2 checkpoint. Mol. Cell. Biol. 2003, 23:4107-4120.
23. Shiraishi S., et al. TBP-interacting protein 120B (TIP120B)/cullin-associated and neddylation-dissociated 2 (CAND2) inhibits SCF-dependent ubiquitination of myogenin and accelerates myogenic differentiation. J. Biol. Chem. 2007, 282:9017-9028.
24. Singleton J.R., Baker B.L., Thorburn A. Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis. Endocrinology 2000, 141:2945-2950.
25. Tanaka Y., et al. Transcriptional repression of the mouse wee1 gene by TBP-related factor 2. Biochem. Biophys. Res. Commun. 2006, 352:21-28.
26. Tapscott S.J. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 2005, 132:2685-2695.
27. Thayer M.J., et al. Positive autoregulation of the myogenic determination gene MyoD1. Cell 1989, 58:241-248.
28. Tintignac L.A., et al. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J. Biol. Chem. 2005, 280:2847-2856.
29. Weintraub H., et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:5434-5438.
30. Weintraub H., et al. Muscle-specific transcriptional activation by MyoD. Genes Dev. 1991, 5:1377-1386.
31. Yogosawa S., et al. Molecular cloning of a novel 120-kDa TBP-interacting protein. Biochem. Biophys. Res. Commun. 1996, 229:612-617.
32. Yutzey K.E., Rhodes S.J., Konieczny S.F. Differential trans activation associated with the muscle regulatory factors MyoD1, myogenin, and MRF4. Mol. Cell. Biol. 1990, 10:3934-3944.